This inventor holds 34 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent, primarily in Serotonin Receptors. Top assignees: Eli Lilly and Company, Eli Lilly Company, Oregon State University. Active years: 1985-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Idianapolis, IN (US) (1999)
- Indianapolis, IN (US) (1985 - 2014)
Company Filing History:
33 out of 4,514 
1 out of 10 
1 out of 328 
Years Active: 1985-2014
Areas of Expertise:
Title: The Innovative Journey of David T. Wong in Neurotransmitter Research
Introduction: David T. Wong is a prominent inventor based in Indianapolis, IN, recognized for his significant contributions to the field of neurotransmitter research. With an impressive portfolio of 34 patents, Wong has made strides in developing novel compounds that address critical aspects of health and medicine. His inventive solutions, particularly in the realm of monoaminergic neurotransmitters, have implications for treating various neurological conditions.
Latest Patents: Wong’s latest patents focus on innovative compounds that act as inhibitors of the transporters or uptake of monoaminergic neurotransmitters. One such patent involves a compound, or a pharmaceutically acceptable salt thereof, described by a specific formula. This compound includes a heterocycle, aryl groups linked by various functionalities, and a diverse range of R substituents, which can be aliphatic, cyclic, or include halides among other options. Additionally, a method for treating subjects is outlined, whereby these compounds or their prodrugs are administered to effectuate relief from neurological disorders. Another notable patent he holds provides methods for inhibiting monoamine uptake in mammals, showcasing Wong's commitment to exploring therapeutic potentials.
Career Highlights: Throughout his career, Wong has held significant positions in reputable organizations, notably Eli Lilly and Company. His work here has positioned him at the forefront of research and development in pharmaceuticals, particularly in formulations aimed at enhancing neurotransmitter functionality.
Collaborations: Collaboration has been a key aspect of Wong's success, with notable coworkers including David W. Robertson and Joseph H. Krushinski, Jr. These professional relationships have fostered an environment of shared knowledge and innovation, leading to impactful advancements in their research areas.
Conclusion: David T. Wong exemplifies the spirit of innovation that drives progress in the medical field. His dedication to developing novel compounds for the treatment of neurological issues continues to make a substantial impact. Wong's contributions not only enhance our understanding of neurotransmitter dynamics but also pave the way for future medical breakthroughs in treating mental health disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile